Aurobindo Pharma consolidated net profit declines 10.28% in the June 2025 quarter
Sales rise 4.48% to Rs 7791.77 crore
Net profit of Aurobindo Pharma declined 10.28% to Rs 824.75 crore in the quarter ended June 2025 as against Rs 919.22 crore during the previous quarter ended June 2024. Sales rose 4.48% to Rs 7791.77 crore in the quarter ended June 2025 as against Rs 7457.65 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var.Sales7791.777457.65 4 OPM %20.5721.70 -PBDT1612.501728.07 -7 PBT1206.801323.89 -9 NP824.75919.22 -10Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 05 2025 | 7:26 AM IST